Advertisement
Screener

CURIS, INC. (CRIS) Diluted Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

CURIS, INC. Diluted Shares Outstanding (Weighted Average)

CURIS, INC. (CRIS) reported Diluted Shares Outstanding (Weighted Average) of 2.14 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14

  • CURIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 2.14M shares, a 238.24% increase year-over-year.
  • CURIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 19.36M shares, a 127.97% increase year-over-year.
  • CURIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 15.78M shares, a 105.38% increase year-over-year.
  • CURIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 15.68M shares, a 163.94% increase year-over-year.
  • CURIS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 13.16M shares, a 108.74% increase from fiscal 2024.
  • CURIS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 6.31M shares, a 19.14% increase from fiscal 2023.
  • CURIS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 5.29M shares, a 13.36% increase from fiscal 2022.
  • CURIS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 4.67M shares, a 94.90% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 6 month as first filedWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Diluted 12 monthWeighted Average Number of Shares Outstanding, Diluted 12 month as first filed
2026-06-302.14M shares
10-Q · filed 2026-08-14
1.56M shares
10-Q · filed 2026-08-14
12.42M shares
derived: average of 3 quarters · filed 2026-08-14
13.24M shares
derived: average of 4 quarters · filed 2026-08-14
2026-03-3119.36M shares
10-Q · filed 2026-05-13
17.57M shares
derived: average of 2 quarters · filed 2026-05-13
16.94M shares
derived: average of 3 quarters · filed 2026-05-13
12.86M shares
derived: average of 4 quarters · filed 2026-08-14
2025-12-3115.78M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
15.73M shares
derived: average of 2 quarters · filed 2026-03-24
10.70M shares
derived: average of 3 quarters · filed 2026-08-14
13.16M shares
10-K · filed 2026-03-24
2025-09-3015.68M shares
10-Q · filed 2025-11-06
8.16M shares
derived: average of 2 quarters · filed 2026-08-14
12.29M shares
10-Q · filed 2025-11-06
8.12M shares
derived: average of 4 quarters · filed 2026-08-14
2025-06-30631.48K shares
10-Q · filed 2026-08-14
12.63M shares
10-Q · filed 2025-08-05
528.70K shares
10-Q · filed 2026-08-14
10.57M shares
10-Q · filed 2025-08-05
5.60M shares
derived: average of 3 quarters · filed 2026-08-14
5.69M shares
derived: average of 4 quarters · filed 2026-08-14
2025-03-318.49M shares
10-Q · filed 2026-05-13
8.09M shares
derived: average of 2 quarters · filed 2026-05-13
7.37M shares
derived: average of 3 quarters · filed 2026-05-13
6.98M shares
derived: average of 4 quarters · filed 2026-05-13
2024-12-317.68M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
6.81M shares
derived: average of 2 quarters · filed 2026-03-24
6.48M shares
derived: average of 3 quarters · filed 2026-03-24
6.31M shares
10-K · filed 2026-03-24
2024-09-305.94M shares
10-Q · filed 2025-11-06
5.88M shares
derived: average of 2 quarters · filed 2025-11-06
5.85M shares
10-Q · filed 2025-11-06
5.83M shares
derived: average of 4 quarters · filed 2025-11-06
2024-06-305.82M shares
10-Q · filed 2025-08-05
5.80M shares
10-Q · filed 2025-08-05
5.79M shares
derived: average of 3 quarters · filed 2025-08-05
5.78M shares
derived: average of 4 quarters · filed 2025-08-05
2024-03-315.78M shares
10-Q · filed 2025-05-06
5.78M shares
derived: average of 2 quarters · filed 2025-05-06
5.76M shares
derived: average of 3 quarters · filed 2025-05-06
5.53M shares
derived: average of 4 quarters · filed 2025-05-06
2023-12-315.78M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
5.75M shares
derived: average of 2 quarters · filed 2025-03-31
5.44M shares
derived: average of 3 quarters · filed 2025-03-31
5.29M shares
10-K · filed 2025-03-31
2023-09-305.72M shares
10-Q · filed 2024-11-14
5.28M shares
derived: average of 2 quarters · filed 2024-11-14
5.13M shares
10-Q · filed 2024-11-14
5.05M shares
derived: average of 4 quarters · filed 2024-11-14
2023-06-304.83M shares
10-Q · filed 2024-08-01
96.69M shares
10-Q · filed 2023-08-03
4.83M shares
10-Q · filed 2024-08-01
96.65M shares
10-Q · filed 2023-08-03
4.83M shares
derived: average of 3 quarters · filed 2024-08-01
4.79M shares
derived: average of 4 quarters · filed 2024-08-01
2023-03-314.83M shares
10-Q · filed 2024-05-07
96.61M shares
10-Q · filed 2023-05-04
4.83M shares
derived: average of 2 quarters · filed 2024-05-07
4.78M shares
derived: average of 3 quarters · filed 2024-05-07
26.50M shares
derived: average of 4 quarters · filed 2024-05-07
2022-12-314.82M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
4.76M shares
derived: average of 2 quarters · filed 2024-02-08
33.72M shares
derived: average of 3 quarters · filed 2024-02-08
4.67M shares
10-K · filed 2024-02-08
93.39M shares
10-K · filed 2023-03-13
2022-09-304.69M shares
10-Q · filed 2023-11-02
93.79M shares
10-Q · filed 2022-11-09
48.17M shares
derived: average of 2 quarters · filed 2023-11-02
4.62M shares
10-Q · filed 2023-11-02
92.37M shares
10-Q · filed 2022-11-09
69.90M shares
derived: average of 4 quarters · filed 2023-11-02
2022-06-3091.65M shares
10-Q · filed 2023-08-03
91.65M shares
10-Q · filed 2023-08-03
91.64M shares
derived: average of 3 quarters · filed 2023-08-03
91.63M shares
derived: average of 4 quarters · filed 2023-08-03
2022-03-3191.65M shares
10-Q · filed 2023-05-04
91.63M shares
derived: average of 2 quarters · filed 2023-05-04
91.62M shares
derived: average of 3 quarters · filed 2023-05-04
91.60M shares
derived: average of 4 quarters · filed 2023-05-04
2021-12-3191.62M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
91.61M shares
derived: average of 2 quarters · filed 2023-03-13
91.59M shares
derived: average of 3 quarters · filed 2023-03-13
91.57M shares
10-K · filed 2023-03-13
2021-09-3091.60M shares
10-Q · filed 2022-11-09
91.57M shares
derived: average of 2 quarters · filed 2022-11-09
91.55M shares
10-Q · filed 2022-11-09
85.17M shares
derived: average of 4 quarters · filed 2022-11-09
2021-06-3091.55M shares
10-Q · filed 2022-08-04
91.53M shares
10-Q · filed 2022-08-04
83.03M shares
derived: average of 3 quarters · filed 2022-08-04
75.91M shares
derived: average of 4 quarters · filed 2022-08-04
2021-03-3191.51M shares
10-Q · filed 2022-05-05
78.77M shares
derived: average of 2 quarters · filed 2022-05-05
70.70M shares
derived: average of 3 quarters · filed 2022-05-05
62.90M shares
derived: average of 4 quarters · filed 2022-05-05
2020-12-3166.03M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
60.29M shares
derived: average of 2 quarters · filed 2022-02-24
53.37M shares
derived: average of 3 quarters · filed 2022-02-24
48.67M shares
10-K · filed 2022-02-24
2020-09-3054.55M shares
10-Q · filed 2021-11-09
47.04M shares
derived: average of 2 quarters · filed 2021-11-09
42.88M shares
10-Q · filed 2021-11-09
2020-06-3039.52M shares
10-Q · filed 2021-08-03
36.99M shares
10-Q · filed 2021-08-03
2020-03-3134.45M shares
10-Q · filed 2021-05-12
2019-12-3133.18M shares
10-K · filed 2022-02-24
2013-03-3180.10M shares
10-Q · filed 2013-05-09
80.03M shares
derived: average of 2 quarters · filed 2014-03-13
79.90M shares
derived: average of 3 quarters · filed 2014-03-13
79.69M shares
derived: average of 4 quarters · filed 2014-03-13
2012-12-3179.97M shares
10-K · filed 2014-03-13
79.81M shares
derived: average of 2 quarters · filed 2014-03-13
79.55M shares
derived: average of 3 quarters · filed 2014-03-13
80.50M shares
derived: average of 4 quarters · filed 2014-03-13
2012-09-3079.64M shares
10-K · filed 2014-03-13
79.35M shares
derived: average of 2 quarters · filed 2014-03-13
80.68M shares
derived: average of 3 quarters · filed 2014-03-13
80.85M shares
derived: average of 4 quarters · filed 2014-03-13
2012-06-3079.05M shares
10-K · filed 2014-03-13
81.19M shares
derived: average of 2 quarters · filed 2014-03-13
81.25M shares
derived: average of 3 quarters · filed 2014-03-13
80.07M shares
derived: average of 4 quarters · filed 2014-03-13
2012-03-3183.34M shares
10-K · filed 2014-03-13
82.35M shares
derived: average of 2 quarters · filed 2014-03-13
80.41M shares
derived: average of 3 quarters · filed 2014-03-13
79.40M shares
derived: average of 4 quarters · filed 2014-03-13
2011-12-3181.35M shares
10-K · filed 2013-03-13
78.95M shares
derived: average of 2 quarters · filed 2013-03-13
78.09M shares
derived: average of 3 quarters · filed 2013-03-13
77.53M shares
derived: average of 4 quarters · filed 2013-03-13
2011-09-3076.54M shares
10-K · filed 2013-03-13
76.46M shares
derived: average of 2 quarters · filed 2013-03-13
76.25M shares
10-Q · filed 2011-10-31
2011-06-3076.38M shares
10-K · filed 2013-03-13
76.10M shares
10-Q · filed 2011-08-04
2011-03-3175.83M shares
10-K · filed 2013-03-13
2010-09-3075.62M shares
10-Q · filed 2011-10-31
75.62M shares
derived: average of 2 quarters · filed 2011-10-31
77.40M shares
10-Q · filed 2011-10-31
2010-06-3075.62M shares
10-Q · filed 2011-08-04
77.98M shares
10-Q · filed 2011-08-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70